NCT03698019 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 159
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 313
- units
- Participants
- groups
- description
- Within 17 days (preferably within 14 days) days after IV over 30 minutes on day 1. Treatment repeats every 3 weeks for 18 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study. Biospecimen Collection: Undergo collection of blood Computed Tomography: Undergo CT Magnetic Resonance Imaging: Undergo MRI Pembrolizumab: Given IV Therapeutic Conventional Surgery: Undergo surgery
- id
- BG000
- title
- Arm I (Adjuvant Pembrolizumab)
- description
- Patients receive pembrolizumab IV over 30 minutes on day 1 every 3 weeks for 3 cycles, then undergo surgery within 3 weeks. Within 84 days, patients receive pembrolizumab IV over 30 minutes every 3 weeks for 15 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study. Biospecimen Collection: Undergo collection of blood Computed Tomography: Undergo CT Magnetic Resonance Imaging: Undergo MRI Pembrolizumab: Given IV Therapeutic Conventional Surgery: Undergo surgery
- id
- BG001
- title
- Arm II (Adjuvant and Neoadjuvant Pembrolizumab)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 88
- value
- 62
- group Id
- BG001
- lower Limit
- 19
- upper Limit
- 90
- value
- 64
- group Id
- BG002
- lower Limit
- 19
- upper Limit
- 90
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 110
- title
- Female
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 203
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 13
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 136
- group Id
- BG002
- value
- 287
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 13
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 141
- group Id
- BG002
- value
- 291
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 14
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 238
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 72
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Missing/Not Reported
- description
- Zubrod's performance-status scores range from 0 to 5, with higher scores indicating greater disability; a score of 0 indicates that the participant is fully active, 1 that the patient is restricted in strenuous activity but is ambulatory, and 2 that the participant is unable to work but is ambulatory and capable of self-care and up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Zubrod Performance Status Score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 270
- title
- Low or Normal
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 43
- title
- High
- description
- LDH denotes lactate dehydrogenase.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- LDH Level
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 126
- title
- IIIB
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 143
- title
- IIIC
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- IIID
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 25
- title
- IV
- description
- Stages are defined according to the American Joint Committee on Cancer 'Cancer Staging Manual', 8th edition.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 153
- group Id
- BG001
- value
- 143
- group Id
- BG002
- value
- 296
- title
- Cutaneous or Unknown
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- title
- Acral
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- Mucosal
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Missing/Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Primary Melanoma Subtype
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 102
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 108
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 101
- title
- Unknown
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- Missing/Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ulceration
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 79
- title
- Mutated
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 126
- title
- Wild-type
- categories
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 51
- group Id
- BG002
- value
- 108
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- BRAF Mutation Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 309
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous BRAF and MEK Adjuvant Therapy
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 310
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Radiotherapy
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 159
- group Id
- BG001
- value
- 154
- group Id
- BG002
- value
- 313
- units
- Participants
- groups
- description
- Within 17 days (preferably within 14 days) days after IV over 30 minutes on day 1. Treatment repeats every 3 weeks for 18 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study. Biospecimen Collection: Undergo collection of blood Computed Tomography: Undergo CT Magnetic Resonance Imaging: Undergo MRI Pembrolizumab: Given IV Therapeutic Conventional Surgery: Undergo surgery
- id
- BG000
- title
- Arm I (Adjuvant Pembrolizumab)
- description
- Patients receive pembrolizumab IV over 30 minutes on day 1 every 3 weeks for 3 cycles, then undergo surgery within 3 weeks. Within 84 days, patients receive pembrolizumab IV over 30 minutes every 3 weeks for 15 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo collection of blood throughout the study and MRI or CT on study. Biospecimen Collection: Undergo collection of blood Computed Tomography: Undergo CT Magnetic Resonance Imaging: Undergo MRI Pembrolizumab: Given IV Therapeutic Conventional Surgery: Undergo surgery
- id
- BG001
- title
- Arm II (Adjuvant and Neoadjuvant Pembrolizumab)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 22
- upper Limit
- 88
- value
- 62
- group Id
- BG001
- lower Limit
- 19
- upper Limit
- 90
- value
- 64
- group Id
- BG002
- lower Limit
- 19
- upper Limit
- 90
- value
- 64
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 48
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 110
- title
- Female
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 203
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 13
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 136
- group Id
- BG002
- value
- 287
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 13
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 3
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 150
- group Id
- BG001
- value
- 141
- group Id
- BG002
- value
- 291
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 14
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 125
- group Id
- BG001
- value
- 113
- group Id
- BG002
- value
- 238
- title
- 0
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 72
- title
- 1
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- 2
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- Missing/Not Reported
- description
- Zubrod's performance-status scores range from 0 to 5, with higher scores indicating greater disability; a score of 0 indicates that the participant is fully active, 1 that the patient is restricted in strenuous activity but is ambulatory, and 2 that the participant is unable to work but is ambulatory and capable of self-care and up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Zubrod Performance Status Score
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 270
- title
- Low or Normal
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 43
- title
- High
- description
- LDH denotes lactate dehydrogenase.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- LDH Level
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 126
- title
- IIIB
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 69
- group Id
- BG002
- value
- 143
- title
- IIIC
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 9
- group Id
- BG002
- value
- 19
- title
- IIID
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 25
- title
- IV
- description
- Stages are defined according to the American Joint Committee on Cancer 'Cancer Staging Manual', 8th edition.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Disease Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 153
- group Id
- BG001
- value
- 143
- group Id
- BG002
- value
- 296
- title
- Cutaneous or Unknown
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 9
- title
- Acral
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 4
- title
- Mucosal
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Missing/Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Primary Melanoma Subtype
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 46
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 102
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 58
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 108
- title
- No
- categories
- measurements
- group Id
- BG000
- value
- 55
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 101
- title
- Unknown
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 2
- title
- Missing/Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ulceration
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 38
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 79
- title
- Mutated
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 62
- group Id
- BG002
- value
- 126
- title
- Wild-type
- categories
- measurements
- group Id
- BG000
- value
- 57
- group Id
- BG001
- value
- 51
- group Id
- BG002
- value
- 108
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- BRAF Mutation Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 151
- group Id
- BG002
- value
- 309
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous BRAF and MEK Adjuvant Therapy
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 3
- title
- Yes
- categories
- measurements
- group Id
- BG000
- value
- 158
- group Id
- BG001
- value
- 152
- group Id
- BG002
- value
- 310
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Previous Radiotherapy
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle